$IXHL — FinTwit mentions on Surfaced

$IXHL — FinTwit mentions on Surfaced

Recent mentions

latest 100 of 101

@dustinhuntwnMar 18, 2026 · 1:47 AM

$IXHL It is true that large pharmaceutical companies such as Pfizer or Eli Lilly could enter as strategic investors but the key point is not the name of the investor itself it is the structure of the deal. When we see elements such as warrants with a Fundamental Transaction clause cash settlement based on the Black-Scholes model the suspension of the ATM program and a 60 day restriction on issuing new shares these are not typically the terms of a standard biotech financing. Structures like this are often used when there is the possibility of a near term strategic event such as an acquisition or a major partnership because the investor wants to ensure they benefit if a change of control occurs. Therefore the issue is not simply that a large investor entered the deal rather the financing structure itself may indicate the potential for an upcoming strategic event.

@dustinhuntwnJan 15, 2026 · 2:55 AM

$IXHL Worth noting: today’s PR completely omitted any mention of partnerships or commercial discussions. That’s a clear shift from earlier 2025, when management regularly referenced strategic and commercial interest. When companies stop using even boilerplate language, it’s often not because nothing’s happening…it’s because they’re constrained in what they can say. Silence is better than hype at this point.

@dustinhuntwnJan 11, 2026 · 3:32 PM

$IXHL at this point we have all thought what is going through management minds to stay quiet for several months, and take all this extensions deadlines. Could either be a master plan to catch everyone offguard🙏 or just pure negligence. a lot of time and money invested here and the business will do what it needs to do to survive. Along the way good and bad choices will be made. Joel to me is a street smarts kinda guy. All speculation on my part. But if that is his style than he will bulldog his way to the finish line. Let’s hope along the way his focus doesn’t distract him from reality. Greed and obsession with success can cause outcomes that are not beneficial for the true success than can be accompished through partnerships and humility. Hoping he makes the right decisions and can guide his company to success.

@dustinhuntwnJan 8, 2026 · 4:47 PM

$IXHL Todays X post isn’t random If an RS were coming, mgmt would be chatty with retail right now..softening the blow, talking “options,” preparing expectations. Instead we get strategic silence and the CEO being elevated in industry media one week before the AGM. https://t.co/G326mJcGSK

@dustinhuntwnJan 7, 2026 · 3:45 AM

$IXHL Fast Track PR (12/3) explicitly said IHL is awaiting FDA’s detailed written response. Given Phase 2 topline was late July + govt shutdown & holidays, a WRO in mid-Jan is a very reasonable expectation. Once WRO arrives, Phase 3 parameters get finalized and partners get written FDA clarity. If commercial discussions have been ongoing (teased since May/July), a commercial update 4–8 weeks post-WRO fits standard biotech timelines. The silence is frustrating, but this is exactly how NDA-bound regulatory + commercial processes look. And this all fits well within the compliance timeframe before April 20th. This is not a lotto ticket. It’s a time bomb that requires a high degree of patience and mental fortitude.

@dustinhuntwnJan 6, 2026 · 3:13 AM

$IXHL 👏 📗📘 that's a nice scorecard! Remember… regardless of the Share Price, this is STILL a Business. Things rarely happen in life “When we WANT them to”!! 🤪 I personally anticipate a major PR event within the next month or so… FDA Fast Track was a Game Changer! 💪 Like I always say, “Stocks and Investing will NEVER Reward the Lazy or Impatient”!! Stay focused… stop concentrating on the Day to Day price action and focus on other productive things in the meantime! (Read some books!) Good luck today all!! 🤙

@dustinhuntwnJan 5, 2026 · 3:07 AM

$IXHL Realistic ResMed-IXHL Timeline 1. Weeks 1-2: Non-binding LOI signed (confidential). 2. Week 3: Accelerated due diligence (IND, dronabinol combo IP, phase 3 sites). 3. Weeks 4-5(We are here): Binding definitive agreement + public 8-K + HSR filing. 4. Weeks 8-12: Tender offer closes → shareholders cashed out.

@dustinhuntwnJan 4, 2026 · 2:12 AM

$IXHL Mgmt actions > words. IHL paid transfer fee to CM and bought back shares at $0.41. small biotech doesn’t do that unless leadership believes the stock is undervalued. Since then: no hype PRs, only required filings and backwards-looking shareholder update with NASDAQ deadline soon. If a reverse split was planned, they’d have done it already. Instead, they paid for an extension, bought back stock, and let price drift. The RSU structure also reinforces confidence: management only benefits if the share price rises. When paired with the company buying back shares and choosing an extension over an R/S, it signals leadership believes intrinsic value is well above current levels. Silence + buyback + RSUs/no further dilution + Fast Track = confidence, not neglect. Don’t let bears or price action wear you down. Company is showing constraint for a reason that will be disclosed soon. The only logical explanation for IHL’s actions (and silence) is they are expecting a major re-rate.

@dustinhuntwnJan 2, 2026 · 3:33 PM

$IXHL Not expecting a deal to be announced at the AGM. But let’s be clear ….Joel will be grilled, and he knows it. While he can’t disclose material events, the tone he sets matters: Reinforcing capital discipline Emphasizing non-dilutive or strategic paths Avoiding reverse-split language Speaking with control, not defense That’s what the market needs to hear right now not details, direction. If Joel handles that well, it’s enough to: Reduce RS fear Stabilize price Set the stage for the real catalyst that comes after via proper disclosure AGM clears the runway. Tone sets sentiment. The reprice comes next. NFA

@dustinhuntwnJan 1, 2026 · 6:17 PM

$IXHL I get why people are shaken by Joel and think he’s not doing what he should — I felt that way too at first. But at the end of the day, the stock going up is in his best interest and in the company’s best interest as well. It helps with partnerships, negotiating from a position of strength, and his own upside. Yeah, the silence can be annoying, but he’s running a company, not a Stocktwits feed. Bottom line, this company has more going for it than most small biotechs, and the data is solid. To me, it’s just a matter of time. I originally came in to trade it, but the more DD I did, the more I realized this is something I want to invest in — even if it takes time. Just my opinion, correct me if I’m wrong.

@dustinhuntwnDec 31, 2025 · 5:40 PM

$IXHL sure some of you won’t mind this, but I’m now going to watch on from the sidelines. It goes without saying, Incannex doesn’t require blue bird to be a successful. The bears really have no influence here and neither do the bulls. This will move positively when the news come and it will come followed by more institutions investing. Without knowing the exact facts, from experience, I can imagine the difficulty Joel has had to deal with knowing father has been up to no good whilst still delivering fantastic business progress. I believe they will partner or sell IHL-42X to someone big. I expect significant news to land in the near future. I will look out for the buy back to be activated before big news is released. I feel their other drugs are currently sleeping giants. I think they will be successful and prove a substantial return on my investment. I no longer need to convince people to be otherwise. I’m ready to rock and roll for what lies ahead. You could follow me, perhaps. I am bullish.

@investmentguru_Dec 31, 2025 · 11:27 AM

$IXHL is one I like at these levels. Enough cash position provides a cushion, and from here it’s a story of execution and momentum.

@dustinhuntwnDec 30, 2025 · 10:04 AM

$IXHL the most positive outcome that Joel did not do. When we were at $1.70, he should have drop some news about doing a buyback, That would have driven the price up to over $2. Then, in a couple of days, we would have been in compliance with Nasdaq. A press release would have been issued once Nasdaq confirmed we were in compliance, and the price would have jumped to over $3. Then I would have used the ATM, the price would have dropped to around $1.50-$2, and then I would have announced that we were closing the ATM, and the price would have soared to $3-$5. Joel is an idiot. He does not care about his shares holders. Still holding believing in the product.

@dustinhuntwnDec 30, 2025 · 8:50 AM

$IXHL institutions are taking profits. There's no signs of selling yet from institutions, despite IXHL falling ~82% from its 52-week high of $2.25. (They are still holding strong with over 4M shares.) 30 longs. 0 short. 0 long/short. They must know something I don't. Watching closely, don't miss out!

@dustinhuntwnDec 30, 2025 · 2:46 AM

$IXHL opinion : pls keep this in mind when you mention share price should have been at $5 or $10 already. Saw it mentioned a few times. Outstanding shares (OS) is at ~350 million currently. We came here because of two outcomes 1. Diluting around 190+ million shares at anything between .08-.15 cents when they absolutely had to dilute to pay off toxic warrants 2. Diluting the rest to raise cash which was last reported around ~73 million. At $5 or $10, this is a market cap or 1.75 Billion to 3.5 Billion. Is this too much dilution ? Considering the deadline for paying off warrants + having cash runway to discuss potential buyout/partnerships, it seems unavoidable. We can't go back in time and change why they raised cash by signing those toxic warrants in the first place.. With all these cleanups, my opinion is the entire BOD is focused on leading the company to right financial outcome.

@dustinhuntwnDec 28, 2025 · 12:23 PM

$IXHL Not sure if everyone remembers this one. IXHL has not phase 3 already started guys? im confused why some say it cant start till we have eop2 min, i think we have been in phase 3 for many months now. https://t.co/UVC1htjcos

@dustinhuntwnDec 26, 2025 · 3:11 AM

$IXHL OVERNIGHT👀 https://t.co/2IslYY3H54

@dustinhuntwnDec 24, 2025 · 3:42 PM

$IXHL I'd be happy to be wrong, but I think that for this year there won't be any relevant news. On the other hand, second and third weeks of January, who knows? I'm anyway super https://t.co/vGwDFRFBkP

@dustinhuntwnDec 23, 2025 · 8:26 AM

Institutions are NOT selling $IXHL. In the past month, institutional ownership of $IXHL has climbed from 1.4M to 4M. • 30 long. 0 short. They probably know something that I don't. Watching closely, don't miss out! https://t.co/K7WJeBAI0o

@dustinhuntwnDec 23, 2025 · 2:37 AM

$IXHL how can anyone deny that 1. The float is locked 2. Something is definitely going on that we are about to find out about. https://t.co/2cSr1Uw5pJ

@dustinhuntwnDec 22, 2025 · 3:06 AM

$IXHL Let's be careful about our over-expectations. This is a biotech. Things will happen when they're meant to happen. You can't rush them. They must follow in line in accordance of protocol. Just let it happen. "Expectation is the thief of joy," Happy is he who expects nothing, as he will never be disappointed. Expectations are like fine pottery. The harder you hold them, the more likely they are to break." Author Brandon Sanderson

@dustinhuntwnDec 21, 2025 · 3:41 PM

$IXHL A very short and dangerous week for bears, yes and for those who scalp here and want to be in when it flies up. This could be the last week in the 04 zone. All the tax offsets have already been implemented, investors are going to come in hard and they have enough reasons this time. Happy Sunday Everyone! Let's have a great Christmas week. Hopefully then, the Santa Rally will also start on the 26th to January 2nd. Then our Meeting. Exciting times ahead of us. Best of luck to everyone!

@dustinhuntwnDec 20, 2025 · 4:48 PM

$IXHL timing interesting - glad the meeting was postponed past year end and especially if major catalyst. Lots of mechanics as far as market right now and having this post rescheduling may be a blessing in disguise. Looking forward to 2026.

@dustinhuntwnDec 20, 2025 · 3:24 AM

$IXHL $MSOS saw a lot of selling on the fund side and possibly repositioning of Advisor Share ETF or however swaps work. I can never fully wrap my head around it. Anyways I expect a float up with thin trading and mostly retail next week. I think January is going to get momentum. We are going to get a lot of press across the sector with rescheduling which I think is going to be good and bring in new retail interests and momo we haven’t had in a long time.

@dustinhuntwnDec 20, 2025 · 3:03 AM

$IXHL Weekend Musings (discuss): 1) we’re waiting on EOP2 feedback specifics from FDA. I anticipate short to medium term net positive SP sentiment and reaction based on what they’ve released so far (Topline results that show minimal safety risk combined with first to market Oral remedy vs garbage CPAP + et al) 2) Cannabinoid rescheduling is a +; net helps us! 3) Cycle Re-ratings: after FTD, we will see updates and increased institutional investment over the next 2 months (quarterly updates) 4) P3 updates: after P2 specifics are shared, we’ll see an increase in P3 update frequency (a known ixhl challenge 🤨) 5) NO 🤞DILUTION needed for P3 (after ATM mostly complete & inactive , P3 is 💯currently funded) 6) I expect ATM and dilution to not be a focus short term. It’s not needed rn. Summary: Either this shit gets bought out or acquired for premium $$$$$$. All 13 employees- or they overhaul the company strategy and prepare for commercialization.

@dustinhuntwnDec 19, 2025 · 5:59 PM

$IXHL how many sold for a loss over the last month bc they couldn’t take the wait ? Sometimes news bakes in slow with Pennies. You have to hold through the fear if you want to get to the moon

@dustinhuntwnDec 19, 2025 · 4:39 PM

$IXHL is this th strangest stock Everyone expected rocket before the meeeting during the netting. NOTHING. It actually drops!!!! Everybody posting POS, yelling at Joel blah blah blah. Amazing no mews(unless I missed it) and it's rocketing. All the bears are silent losing their Xmas money. The people thatve been here for the long haul hopefully will be rewarded

@dustinhuntwnDec 19, 2025 · 3:17 AM

$IXHL don’t forget, insiders didn’t sell a single RSU after 12/10. Insider confidence is high. Stop ruminating. Don’t listen to “them”. Nothing has changed. IHL’s assets are now acceptable in the mainstream with schedule 3. We are fast tracked. We serve a 10B addressable market with low compliance to CPAP. Our only competitor is a stimulant that likely doesn’t treat all forms of OSA. And that’s only our lead asset. 2 more in the pipeline, one being RA which could eventually take over the spotlight of 42x with a 50B addressable market. Plus many other cannabinoid patents and no toxic finances. 70M cash runway. What more can you ask for besides a higher stock price? Joel doesn’t seem worried about compliance. Tutes buy-in when p2 feedback is positive. It’ll come, it has to after FTD. The rationale behind the suppression of this stock is obvious. No explanation is required if you have done proper research. Happy holidays ya’ll. I’m lying low until next PR.

@dustinhuntwnDec 18, 2025 · 2:52 PM

$IXHL They are succeeding.......at lessening the amount that retail will hold once the time comes. Sad but true. Incannex wants institutional holders as majority, not retail. I mean give me a break, a couple days before the AGM and there was a trivial error which postponed a very hyped meeting, their first from Dubai??? Pure strategic fear placed on retail to get them to sell. Good thing I'm old and stubborn and not scared of anything...

@dustinhuntwnDec 18, 2025 · 3:01 AM

$IXHL Going nationwide now ... ABC News.... $TLRY $MSOS $CGC https://t.co/szDpCrGvp4

@dustinhuntwnDec 17, 2025 · 2:41 AM

$IXHL just for all those who keep insisting this isn’t a “weed stock” now you will think again. This is not retail buying. Look across the sector now. Statement from trump last night was rescheduling will help research - this is for medical research on cannabinoids- keep watching. We have two days until investor meeting. Remember this stock is held in Psil ETF

@acinvestorblogDec 16, 2025 · 5:20 PM

$IXHL small cannabis name... still on watch. DTL at 43c now. Once it breaks the DTL everything is possible. Weed names are hot "Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on April 27, 2001 and is headquartered in Norwest, Australia".

@dustinhuntwnDec 16, 2025 · 5:01 PM

$IXHL RESHARE THIS. I’d like to bring this conversation here back to the actual value of Incannex and what it is standing for. There is far too much opinion being lauded about without actual evidence. Incannex is a clinical-stage biotech focused on obstructive sleep apnea, with lead asset IHL-42X, an oral fixed-dose combination targeting OSA via two complementary mechanisms. Phase 2 RePOSA data showed strong, dose-dependent AHI reductions, with improvements in oxygenation and sleep quality, supporting a clear efficacy signal. That data supported FDA Fast Track designation, enabling closer FDA engagement. OSA is a multi-billion-dollar market with high CPAP non-compliance, making an effective oral therapy structurally differentiated. The program is backed by patents covering the specific combination and dosing, and Incannex is not a single-asset company, with additional earlier-stage inflammatory and pain programs.

@dustinhuntwnDec 16, 2025 · 3:19 AM

$IXHL here's how it goes down... shortie goes to bed one night patting himself on the back for bashing all day and taunting the bulls, he has sweet dreams about driving his Lambo and taking lavish vacations, thinks the price will just walk it's way down to .0000000000001 and then he covers and posts "I told all you losers that this co will go bankrupt, nobody needs a sleep apnea pill, they'd rather wear a bulky uncomfortable mask to try to sleep every night until they die"... But then the alarm clock goes off and he goes to his computer to see the MASSIVE LOSS AND HIS SCREEN BLINKING MARGIN CALL!! - MARGIN CALL!! - MARGIN CALL!!... He looks at his position size and it says ZERO... the broker has covered for him at $7.55 and he's down 1,500 %... he scrambles to look at the news and the PR was dropped about $IXHL being bought out for $7.50 / share... he picks up the phone to call his Mommy to see if his bed is still in the basement and make sure she has Mac n cheese... too bad, so sad...

@dustinhuntwnDec 15, 2025 · 4:51 PM

$IXHL 70% of the last months volume has been off exchange. Thats not normal, nothing should ever be this manipulated. Further, 56% of all volume on this stock over that time has been short volume. I dont know how this can ever be more obvious. They cant hold this down like this forever, eventually they will have to let off.

@dustinhuntwnDec 15, 2025 · 4:11 PM

$IXHL let’s say no news before AGM. What’s changed? Nothing. Absolutely nothing. Joel can’t make FDA provide feedback this week. He can’t rush any partner negotiations. He shouldn’t issue buyback if the timing isn’t ripe. I still think something will be released, but won’t be shook if it doesn’t. Don’t let your emotions take over this week. We have a little over 4 months to make these things happen and valuation will rerate itself. People take the hype of this board as gospel. Nobody here knows what’s going on behind the scenes. Company just hit one of its biggest milestones in fast track. Joel is still moving forward in a positive direction, regardless of the market’s sentiment.

@dustinhuntwnDec 15, 2025 · 2:03 AM

$IXHL $TLRY CBS news article published 5 hrs ago: Medical cannabis access could expand Supporters say Schedule III status could legitimize medical cannabis and bring it into mainstream healthcare. "At Schedule 3, it's much more practical for mainstream physicians to prescribe cannabis products," Hunter said, adding that patients in states without medical marijuana programs could benefit most. Mark Lewis, President of Specialty Banking at Lüt, called rescheduling "the single most important drug policy move in decades," citing expanded research opportunities and broader access for patients nationwide.

@dustinhuntwnDec 14, 2025 · 5:09 PM

$IXHL Hello everyone. As we head into what could be a life changing week for many including myself, here is my final thesis which is bullish. These points are listed in the order of priority for my mind and my trading. As always this is just an opinion and I am not offering any financial advice. Why I am a long term buyer of $IXHL 1. The company is a good company with solid and innovative offerings. Unlike a lot of biotech, it has multiple medications progressing through the approval process. There is a very friendly administration who is signaling administrative support based on literature for utilizing cannaboids and hallucinogens (microdosed). These medications have a very wide set of conditions for which they are useful, and the literature, theory, receptors targeted with these medications all very much so make clinical sense to me. It has an unusually wide moat for a stock this size, and it all looks promising. 2. The balance sheet is improving and fairly clean at this point. Understanding the dilution required for having liquidity for the tight spots where cash is an issue, while not liking being diluted, it is reasonable to understand why it was done. More importantly, share buyback having been initiated, as well has having phase 3 fully funded seriously reduces the risk of investing. 3. Technical analysis over the last 90 days is solidly bullish. Higher higher and higher lows. We have some superb technicians on this board. While I believe technical analysis is importsnt, to be it helped me confirm my conviction. It is difficult to trade on technical factors alone. In the case of this stock, the technicals are falling in line with the leading indicators. Remember technical analysis is only able to look at the past. Still nice to see significant uptrend. 4. From a strategic standpoint it looks like company leadership is foreshadowing what is to come. Stocks that are iffy or dead in the water are not moving to international hubs know. For both wealth and major names in the same city. Particularly since Dubai has Particularly zeroed in on biotech. From fundamentals to financials to the trend on the chart to upcoming events I believe all elements are aligned and the fast tracking of its first drug certainly is turning heads. FDA wants this drug on the market briskly. In some ways I thought this week would never get here. But here we are. The work is done everyone is in a position they think is best for themselves including me. To best of luck to all this week. I am sure Tuesday night into Wednesday morning until PM I will be hyperventilating. Maybe we should have an overnight party as the AGM progresses. I will bring the Disoranto or the 21 year old Irish whisky and hope to toast all bulls with a shiny new 1.xx handle on the tape. Be well.

@dustinhuntwnDec 13, 2025 · 5:00 PM

$IXHL IMO i feel like were heading for a BO. Joel has suitors lining up to pay. He has no intention of carrying this through. Hence why he is unfazed abour RS compliance, the granting of RSUs, the company being cleaned and primed for a BO, the absolute silence (NDA) etc.

@dustinhuntwnDec 13, 2025 · 3:32 AM

$IXHL if Joel times the next PR right after trump signs executive order for schedule III….he should be considered a master of his craft. If it’s a partnership + EOP2 feedback going into AGM, he should be considered a legend. Would love to see it. Time will tell.

@dustinhuntwnDec 12, 2025 · 5:23 PM

$IXHL People assume Joel means poorly, but don't understand that there are legal (and illegal) ways for ill-meaning competitors, or greedy entities that slither around in the dark pool to negatively affect the stock. Maybe that assumption isn't the best to lean on in most cases, but for this stock in particular, it's looking far more likely than "bad CEO, company hates investors." That surface level sentiment is exactly what they want retail to think - so that they can get away with suppressing a competitor or accumulating as many shares as they can for themselves. This company is doing everything it takes to succeed, and I trust them to do it. Of course they don't care for any of us individually, but they absolutely care about shareholders and shareholder value. Support the company. Support their vision. Let them cook. Don't assume you know better about something that these people have done and have been doing for the majority of their time spent awake on this planet. Much love & nfa.

@dustinhuntwnDec 12, 2025 · 4:08 PM

$IXHL 🚀 Cannabis rescheduling to Schedule III Big Pharma gets the green light for cannabinoids IXHl owns one of the biggest patented portfolios(more than 10) but only 3 drugs in trials. The rest? Dormant gold waiting for partners/buyouts. Rescheduling ignites the fuse. 🔥

@dustinhuntwnDec 12, 2025 · 1:14 AM

$IXHL Fast track and trump reclassified marijuana is a good set up. Not by chance but by “meant to be”. if cannabis is really changed to schedule 3 the current share price becomes even more absurdly undervalued. We need to move up. https://t.co/OaLd7S9Y2H

@dustinhuntwnDec 11, 2025 · 4:46 PM

$IXHL IGNORE the RS fearbait. If a partnership/JV or major catalyst is in motion (which the signals suggest), there is zero incentive for the company to reverse split before revealing it. An RS is only used when a company has nothing coming. The CEO moving operations to Dubai and scheduling a 12/18 AGM there is not the behavior of a company preparing for a dilution spiral it’s the behavior of a company preparing for a deal. Stay focused on the actual setup, not the noise.💪

@dustinhuntwnDec 11, 2025 · 3:45 AM

$IXHL Re whether the company will release the End of Phase 2 ("EOP2") notes it receives from the FDA: To my understanding, an EOP2 meeting is not in of itself a material event. However, many if not most of what the FDA has to say is material and must be disclosed to shareholders, along with many of the company's decisions and actions in response. In addition, no NDA can override a company's mandatory material disclosure duties, as a matter of securities law and public policy. Furthermore, IXHL essentially promised in its last PR that it will release the FDA's EOP2 notes after it receives them. In my view, all of this makes the company's release of the EOP2 meeting notes the most dependable next catalyst, coming any day now.

@dustinhuntwnDec 10, 2025 · 2:20 PM

$IXHL My friend is a medical practitioner. She looks at $IXHL through clinical reality, not hype. Proof, not speculation. The data behind IHL-42X is genuinely stronger than what she typically sees in early-stage therapeutics, and the efficacy of this pill stands well above the average. This is a true pioneer medicine with real potential to change how we treat sleep-related breathing disorders. That’s why she sees massive potential here both medically and as an investment. Real movement will occur sooner than later. There is no one here with a DCA that will not break even and then some. Be patient.

@dustinhuntwnDec 10, 2025 · 3:10 AM

$IXHL Tomorrow is the interest rate decision day. If market sentiment is negative, you'd better be prepared for a potential drop of 0.3500. I believe there might be a blackout period for the RSUs to vest. I believe companies can’t do a PR on same day of RSU vesting. Not 100% on this. But I believe that to be true. I also believe this is why MMs are comfortable taking the price down right now to accumulate. They know nothing is coming out tomorrow from the company. Someone correct me if I’m wrong. But my take is don’t get your hopes up tomorrow.

@dustinhuntwnDec 8, 2025 · 4:50 PM

$IXHL seems there is some frustration with this lil pullback. For me nothing has changed. Ixhl will do everything in there power to avoid the shit show and stigma that comes along with a r/s. We have loads of news that is due any day now. Charts and candles sticks carry very little weight when dealing with a biotech penny play imo . I’m chillin and confident as ever.

@dustinhuntwnDec 8, 2025 · 3:44 PM

$IXHL short attack. Just hold.

@dustinhuntwnDec 7, 2025 · 5:19 PM

$IXHL Another company (Novo) with close ties to Incannex already has its Middle East headquarters in Dubai, suggesting a strategic co-location IMO.

@dustinhuntwnDec 7, 2025 · 7:13 AM

$IXHL Thats only a 3.4 Billion market cap for 3 pipelines one of which got fast tracked fda designation. 2 of which have exceptional EoP2 results with rigorous safety profiles. Wonder who our lucky partner will be.

@dustinhuntwnDec 5, 2025 · 2:32 AM

$IXHL Been holding since I bought back in May. Never sold a share. When I saw the stock price of this thing and the phase 1 data side by side, this seemed like a fantastic investment for the price. Huge upside potential. They had shown safety and efficacy in a small sample size. RePOSA bummed me out a little bit honestly. 41% and 15% of participants saw >30% and >50% reduction in AHI respectively. I thought wow, not even half of the participants saw a .5 reduction in their symptoms. But then fast track happened. So here's the thing. I know just a little about industry and the FDA. Just a tiny little bit...FDA isn't going to give fast track status to a drug with subpar efficacy. If the FDA finds the efficacy meaningful I have a good feeling doctors will too. That means scripts. That means sales. So far this thing has shown great safety and efficacy. What more do you want bears? If you beat a dead horse too long it might get up and kick you in the wallet.

@dustinhuntwnDec 4, 2025 · 4:42 PM

$IXHL 0 👀 https://t.co/cZf7ep8Ogd

@dustinhuntwnDec 4, 2025 · 3:15 PM

$IXHL fomos you got your confirmation to step in what are you waiting for. There is money to be made today and tomorrow. LFG!!!!!!! https://t.co/GnUXeh5iNK

@dustinhuntwnDec 4, 2025 · 9:34 AM

$IXHL For those who didn't notice yesterday. A minute before the news, the price dropped and then the huge green candle of the PR arrived. Be careful selling on declines, you don't know which candle will come after them, sell in a clear trend and buy in a clear trend. https://t.co/7tu1lm6l9d

@dustinhuntwnDec 4, 2025 · 2:03 AM

$IXHL I can tell you this all they want is your shares cheaper. Can’t wait for what’s coming next, Dubai is 10 trading days away! And the M&A line outside Joel’s Office after the news today is getting longer and longer! Fast track makes the process to product less then 12 months! The combination of our drug is already aproven and used! 83% reduction, zero side effects that’s quite something world class!

@dustinhuntwnDec 3, 2025 · 6:20 PM

$IXHL … all facts , no spin https://t.co/hVodK9qTsn

@dustinhuntwnDec 3, 2025 · 6:03 PM

$IXHL we are better positioned now then back in July when we touched 1.60’s Crazy how we are still under a buck

@dustinhuntwnDec 3, 2025 · 4:50 PM

@mikealfred $IXHL !!!

@dustinhuntwnDec 3, 2025 · 4:36 PM

$IXHL Ceo said 👇 "We believe Fast Track designation for IHL-42X is one of the most significant regulatory milestones in Incannex’s history," said Joel Latham, President and CEO of Incannex. "OSA affects millions of people globally, yet there remains no approved oral pharmacotherapy, a gap we are determined to close." ------------ Imo, There's at least 900MM+ POTENTIAL PATIENTS SUFFERING OSA DAILY... Let me repeat.. DAILY SUFFERING OSA ✅️ Future's revenues IS staggering... Worth multiple billions of dollars annually for $IXHL to dominate. - imo

@dustinhuntwnDec 3, 2025 · 4:22 PM

$IXHL for any new comers, FDA fast track is NOT a scam. Secondly, the bears here were betting this was not gonna get fast track approval and reverse split. They were betting against that never happening. Today they got a middle finger from IXHL. Tune them out.

@dustinhuntwnDec 3, 2025 · 4:17 PM

$IXHL Read and re-read….Then sit back and wait until 12/18/2025. You can thank me later Charts, price, volume…all means nothing rn. Filings and PR is all we’re waiting on.

@dustinhuntwnDec 3, 2025 · 3:32 AM

$IXHL People are still sleeping on what IHL-42X actually represents. An 83% reduction in AHI in Phase 2 is on a level that most companies in this space never achieve. If Phase 3 confirms even half of that efficacy, the valuation reset could be massive — easily far beyond where the current market cap is sitting. This isn’t hype, it’s just simple math once the data gets recognized IXHL Team Strong trading the last few sessions especially today's. Looks like we may have finally broken the barcode l. What's everyones thoughts going forward from here ? Strength in numbers I'd say.

@dustinhuntwnDec 2, 2025 · 4:59 PM

$IXHL starting to like the daily chart looking for a break above 0.38 for that 0.40 breakout resistance test https://t.co/EkurjDYXtf

@dustinhuntwnDec 2, 2025 · 4:37 PM

$IXHL showing something interesting today 👀 Over 80% of all volume traded off-exchange — highest in weeks. Often signals quiet accumulation or larger orders being executed in the background 📈 Keeping an eye on VWAP + momentum the next sessions.

@dustinhuntwnDec 2, 2025 · 3:56 AM

$ASST $BYND $IXHL Today, on my Webull account, I received a notification that I may have to register with SEC under "large trader rule". Confused, I looked it up. If you buy 2 million shares/ $20 million on a calendar day or 20 million shares/ $200 million in a calendar month, you must file a 13 H. Are they f#&king with me? I have 125,000 shares. Has this happened to anybody else?

@dustinhuntwnDec 1, 2025 · 4:31 PM

$IXHL Market red, IXHL rollercoaster but green. Nice https://t.co/MSZ6y1RcOr

@dustinhuntwnNov 30, 2025 · 3:38 PM

$IXHL I like what I’m seeing https://t.co/hgMwfTAVbd

@dustinhuntwnNov 30, 2025 · 4:05 AM

$IXHL seems like a cause for celebration in a new home- (instead of a boring shareholders meeting) Dubai! https://t.co/fLBGzN6xeU

@dustinhuntwnNov 29, 2025 · 4:13 PM

$IXHL it’s a week and half before 12.10 , the first vested shares date so I think if there’s any negotiations happening / other PRs building in the background they’ll need to announce before this date? The signals are there for an upcoming rerate! Bring it onnn!💥💥💥

@dustinhuntwnNov 29, 2025 · 2:36 PM

$IXHL Think strategically. Incannex is not acting like a typical small biotech company and we’re abt to find out why…. https://t.co/2qANqDr7kp

@dustinhuntwnNov 22, 2025 · 6:39 PM

$IXHL - this may be the “one” to get framed for the poolroom. https://t.co/SJhvUwARy3

@dustinhuntwnNov 22, 2025 · 2:58 PM

$IXHL this is what you need to know about ixhl if you dont have an idea…it’s coming…patience …believe…stop whining and ignore the noise… https://t.co/OmwKBCiynS

@dustinhuntwnNov 21, 2025 · 9:13 PM

$IXHL if you cant handle the pressure move on ,this game is not for the weak https://t.co/AawLnHc2pl

@dustinhuntwnNov 21, 2025 · 4:21 PM

$IXHL people saying "just buy the dip and average down"..bruh ive been doing that for the past however months. Theres only so much money (and risk) i can pump into this. Everytime it finds a way to go lower🤔 Holding! https://t.co/EgMtiL2zZS

@dustinhuntwnNov 21, 2025 · 9:24 AM

$IXHL crazy to me how the short buyers have such a large position knowing that at any moment news could be released. They know the news is coming…. But they think it’s worth a small profit to take that kind of risk. Crazy to me… crazy.

@dustinhuntwnNov 20, 2025 · 5:17 PM

$IXHL Updated coverage… https://t.co/6Ui0uP1C5E

@dustinhuntwnNov 20, 2025 · 9:40 AM

$IXHL At ResMed’s AGM last night the governance slate is locked: retirements formalized, Nicole officially seated, shareholder ratifications queued. From that moment forward, the board has a clean mandate with Nicole at the helm, her pristine rep precedes her. That means any day after yesterday becomes a viable announcement window—they no longer risk optics friction from unsettled board composition. The AGM is the last governance hurdle. Precedent in Pharma M&A • Johnson & Johnson / Intra‑Cellular (2025) → Deal announced on a Monday premarket, just days after governance prep was finalized. • AbbVie / Allergan (2019) → Announcement staged immediately after board approvals, with optics cleared before reveal. • Pfizer / Wyeth (2009) → Governance slate locked, deal announced within days. BTMFD while you still can

@dustinhuntwnNov 19, 2025 · 3:57 PM

$IXHL This next 2 months is all about FDA progress and partnerships. Know the timeline, understand the cash runway, and hold based on the story, not daily swings.

@dustinhuntwnNov 18, 2025 · 10:05 AM

$IXHL New load the boat day for me 🤩 https://t.co/0ac1aJMKt3

@dustinhuntwnNov 17, 2025 · 3:31 PM

$IXHL This is going crazy. It is a great sign. Expecting to see more this week https://t.co/aAcITKaqbi

@dustinhuntwnNov 14, 2025 · 4:02 PM

$IXHL Welcome to the 3 new Tuts today ☺️ https://t.co/7DzULy9SRY

@dustinhuntwnNov 13, 2025 · 9:54 AM

$IXHL nice start to the day. Remember the potential here. My personal aim is to see Incannex pass a $1 billion MC. This is a challenge of course but absolutely achievable. It would see the price at around $2.8 - $3. Now if there’s an acquisition, now that’s another scenario… 💰 Open question, what do we think a realistic acquisition price is?

@dustinhuntwnNov 13, 2025 · 1:49 AM

$IXHL oh thank God this shutdown is over ... time to get the party started

@dustinhuntwnNov 12, 2025 · 4:47 PM

$IXHL Me and big boys loading here knowing the risk and reward 😉😎 0.33$ to 12.66$ https://t.co/FhqBXeZ32U

@dustinhuntwnNov 12, 2025 · 4:16 PM

$IXHL one more- 6 figure investment https://t.co/Nv6jVFDqHk

@dustinhuntwnNov 12, 2025 · 1:16 PM

$IXHL Will it take 3 trading days to cover all the borrowings? This is an interesting statistic that I haven't seen for a long time here. The volume rate here is definitely discouraging not only shareholders but also shorts. A good time to go up parabolically and surprisingly https://t.co/AUOsjrQsEm

@dustinhuntwnNov 12, 2025 · 1:12 PM

$IXHL have a feeling that they sold high when it was above 1$ and have repurchased quite a lot of shares in the 0.33-37 range, generating a shit ton of cash to bootstrap phase 3, and limiting the dilution by buying back. This will be reported in the earnings report and it will lift the share price above the $ Hang tight my friends, we haven’t even started our ride. Best, ;)

@dustinhuntwnNov 11, 2025 · 12:53 PM

$IXHL 7m shares on the 4$ ask waiting to be routed https://t.co/vb5w5NluvK

@dustinhuntwnNov 10, 2025 · 4:06 PM

$IXHL Citigroup increases their stake by 571% and owns 177k shares. Filed today. Hope to see a few more of these this week. https://t.co/1xq8JSO280

@dustinhuntwnNov 10, 2025 · 12:15 PM

$IXHL They are covering on both sides 😎 https://t.co/7LHtCBJ0kR

@dustinhuntwnNov 8, 2025 · 4:41 PM

$IXHL get this over a day FAFO https://t.co/C2GYb5FB6G

@dustinhuntwnNov 7, 2025 · 4:55 PM

$IXHL If anyone is panicking about the FDA “moving the goalposts,” that mess is inside the Biologics and Gene Therapy division (CBER). $IXHL develops small-molecule and psychedelic-based drugs (IHL-42X for sleep apnea, PSX-001 for GAD) Those are reviewed under CDER, which hasn’t changed its standards. The selloff hitting speculative biotechs is sector-wide fear, not a direct hit to IXHL’s regulatory path. In my opinion, this overreaction could be a buying opportunity once the dust settles.

@dustinhuntwnNov 7, 2025 · 2:00 PM

$IXHL and another investor. 9 in the last 20 days https://t.co/CZV2QJChzc

@dustinhuntwnNov 6, 2025 · 1:21 PM

$IXHL Advisor shares PSIL etf shows additional 179,434 shares on their website compared to the last filing on fintel on 25th of August https://t.co/b35P6Yhgqk

@dustinhuntwnNov 5, 2025 · 12:13 PM

$IXHL This is someone trying to drive the price down hitting the BID from .3422 all the way down to .3399 with about 5000 shares. If you ever have wondered if they are selling or buying, use the time stamp and see the direction of the price. https://t.co/gEQ3iEfEhE

@dustinhuntwnNov 4, 2025 · 3:52 PM

@mikealfred Any thoughts on $IXHL here?

@dustinhuntwnNov 3, 2025 · 3:02 PM

$IXHL Whoever think ResMed is going to go under because Incannex has a pill for OSA (IHL-42X) is wrong and delusional. They (ResMed) are watching this like hawks and will either be part of the plan or will amend their operational strategy. There are too many well entrenched investors in ResMed & they will not allow it to falter. Whereas IHL-42X is without a doubt a game changer. Mind you, there are a plethora of people out there who may not tolerate a pill and require a CPAP machine.

@dustinhuntwnOct 31, 2025 · 5:19 PM

$IXHL if I won the lottery I’d dump so much money into this for two reasons. 1:) $IXHL is a real company, with real drugs being used in real clinical trials on real people… with very real STATISTICALLY SIGNIFICANT results. Not to mention the extremely high potential to help improve people’s lives if these two drugs meet their primary endpoints in phase 3. 2.) Just to absolutely burn whoever scooped up all those short shares and let the paper handed bulls make their money back or a nice profit

@dustinhuntwnOct 31, 2025 · 4:51 PM

$IXHL coil tightening near 0.38 with low volume. Watching 0.39–0.40 for breakout confirmation. In my opinion, company still sitting on roughly $115M cash value, yet trading far below that level. Setups like this don’t stay quiet long. https://t.co/oFFOkIfCQP

+ 1 more